ABVD vs. COPPEBVCAD (CEC) vs. BEACOPP for the initial treatment of patients with advanced Hodgkin lymphoma(HL). Preliminary results of HD2000 GISL trial

被引：0
|
作者：
Federico, M. [1 ]
Luminari, S. [1 ]
Olio, M. Dell' [2 ]
Merli, F. [3 ]
Brugiatelli, M. [4 ]
Stelitano, C. [5 ]
Mammi, C. [1 ]
Musso, M. [6 ]
Baldini, L. [7 ]
Marcheselli, L. [1 ]
Gobbi P G, P. G. [8 ]
机构：
[1] Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy
[2] AO Casa Sollievo Sofferenza, San Giovanni Rotondo, FG, Italy
[3] AOS Maria Nuova, Reggio Emilia, Italy
[4] AO Papardo, Messina, Italy
[5] AO Bianchi Melacrino Morelli, Reggio Di Calabria, Italy
[6] AO La Maddalena, Palermo, Italy
[7] Osped Maggiore, IRCCS, Milan, Italy
[8] Univ Pavia, Med Clin, I-27100 Pavia, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [31] Comparison of interim PET (iPET) response to relapse vs. first-line treatment in children with classical Hodgkin lymphoma (HL) - contribution to the development of response criteria for relapsed HL
    Kluge, Regine
    Wittig, Tim
    Hasenclever, Dirk
    Kurch, Lars
    Georgi, Thomas
    Sabri, Osama
    Mauz-Krholz, Christine
    Koerholz, Dieter
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [32] Eight cycles of BEACOPP escalated compared with 4 cycles of BEACOPP escalated followed by 4 cycles of BEACOPP baseline with our without radiotherapy in patients in advanced stage Hodgkin Lymphoma (HL): Final analysis of the randomised HD12 trial of the German Hodgkin Study Group (GHSG)
    Eich, H. T.
    Mueller, R-P.
    Haverkamp, H.
    Gossmann, A.
    Staar, S.
    Kriz, J.
    Lukas, P.
    Willich, N.
    Engenhart-Cabillic, R.
    Engert, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 : 26 - 26
  • [33] The Meteor Trial: Preliminary Results of an RCT of Arthroscopic Partial Meniscectomy Vs. Physical Therapy in Patients greater Than 45
    Katz, Jeffrey N.
    Chaisson, Christine E.
    Cole, Brian
    Donnell-Fink, Laurel
    Jones, Morgan
    Levy, Bruce
    Mandl, Lisa A.
    Martin, Scott
    Marx, Robert
    Miniaci, Anthony
    Palmisano, Joseph
    Reinke, Emily
    Safran-Norton, Clare
    Skoniecki, Debra J.
    Solomon, Daniel Hal
    Spindler, Kurt P.
    Wright, John
    Wright, Rick
    Losina, Elena
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1123 - S1123
  • [34] RANDOMIZED CONTROLLED TRIAL OF MAGNETIC SPHINCTER AUGMENTATION (MSA) VS. OMEPRAZOLE IN GERD PATIENTS WITH REGURGITATION: INITIAL RESULTS FROM THE CALIBER TRIAL
    Bell, Reginald
    Lipham, John
    Louie, Brian E.
    Williams, Valerie
    Luketich, James D.
    GASTROENTEROLOGY, 2017, 152 (05) : S1309 - S1309
  • [35] Eight Cycles of BEACOPP Escalated Compared with 4 Cycles of BEACOPP Escalated Followed by 4 Cycles of BEACOPP Baseline with Our without Radiotherapy in Patients in Advanced Stage Hodgkin Lymphoma (HL): Final Analysis of the Randomised HD12 Trial of the German Hodgkin Study Group (GHSG)
    Diehl, Volker
    Haverkamp, Heinz
    Mueller, Rolf Peter
    Eich, Hans Theodor
    Mueller-Hermelink, Hans Konrad
    Cerny, Thomas
    Markova, Jana
    Ho, Anthony
    Kanz, Lothar
    Greil, Richard
    Hiddemann, Wolfgang
    Engert, Andreas
    BLOOD, 2008, 112 (11) : 552 - 553
  • [36] Long Term Follow-up Analysis of HD9601 Trial Comparing ABVD Vs Stanford V Vs MOPPABVCAD in Patients with Newly Diagnosed Advanced Stage Hodgkin Lymphoma. A Study from the Intergruppo Italiano Linforni (IIL).
    Chisesi, Teodoro
    Bellei, Monica
    Luminari, Stefano
    Marcheselli, Luigi
    Levis, Alessandro
    Vitolo, Umberto
    Stelitano, Caterina
    Pavone, Vincenzo
    Merli, Francesco
    Liberati, Marina
    Baldini, Luca
    Bordonaro, Roberto
    Pesce, Emanuela
    Gobbi, Paolo
    Federico, Massimo
    BLOOD, 2008, 112 (11) : 902 - 902
  • [37] Stanford V (SV) versus ABVD for adult patients with advanced Hodgkin's disease (HD): Preliminary results of a randomized phase II trial from the BNLI.
    Sweetenham, J
    Smith, P
    MacMillan, A
    Cunningham, D
    Hoskin, P
    Horwich, A
    Linch, D
    BLOOD, 2000, 96 (11) : 249B - 249B
  • [38] A Randomized Phase III Trial of ABVD Vs. Stanford V +/- Radiation Therapy In Locally Extensive and Advanced Stage Hodgkin's Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperatve Oncology Group (E2496)
    Gordon, Leo I.
    Hong, Fanxing
    Fisher, Richard I.
    Bartlett, Nancy L.
    Connors, Joseph M.
    Gascoyne, Randy D.
    Wagner, Henry
    Stiff, Patrick J.
    Cheson, Bruce D.
    Gospodarowicz, Mary
    Advani, Ranjana
    Kahl, Brad
    Friedberg, Jonathan W.
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph
    Hoppe, Richard
    Horning, Sandra J.
    BLOOD, 2010, 116 (21) : 185 - 185
  • [39] Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and Involved Field Radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin Lymphoma (HL): An analysis of the GHSG HD14 trial
    Eich, H. T.
    Borchmann, P.
    Kriz, J.
    Pluetschow, A.
    Fuchs, M.
    Engert, A.
    Mueller, R. -P.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 77 - 77
  • [40] Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial
    Sieber, M
    Tesch, H
    Pfistner, B
    Rueffer, U
    Paulus, U
    Munker, R
    Hermann, R
    Doelken, G
    Koch, P
    Oertel, J
    Roller, S
    Worst, P
    Bischof, H
    Glunz, A
    Greil, R
    von Kalle, K
    Schalk, KP
    Hasenclever, D
    Brosteanu, O
    Duehmke, E
    Georgii, A
    Engert, A
    Loeffler, M
    Diehl, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 276 - 282
12345